We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+18.15%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$4.84M
Cap. Flow
-$3.33M
Cap. Flow %
-2.77%
Top 10 Hldgs %
38.28%
Holding
176
New
49
Increased
27
Reduced
29
Closed
53

Top Buys

Rank Stock Value
1
GDEN
Golden Entertainment
GDEN
+$5.43M
2
WBD icon
Warner Bros
WBD
+$5.05M
3
RNAM
Avidity Biosciences
RNAM
+$3.49M
4
KW
Kennedy-Wilson Holdings
KW
+$3.07M
5
GRND icon
Grindr
GRND
+$2.88M

Top Sells

Rank Stock Value
1
WOW
WideOpenWest
WOW
+$4.89M
2
DK icon
Delek US
DK
+$3.71M
3
ARVN icon
Arvinas
ARVN
+$3.27M
4
KROS icon
Keros Therapeutics
KROS
+$2.84M
5
SGRY icon
Surgery Partners
SGRY
+$2.68M

Sector Composition

Rank Sector Weight
1 Healthcare 32.77%
2 Real Estate 10.33%
3 Consumer Discretionary 9.43%
4 Communication Services 9.34%
5 Technology 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BUR icon
51
Burford Capital
BUR
$922M
$517K 0.43%
58,000
+3,000
+5% +$29.4K
GPACU
52
General Purpose Acquisition Corp Units
GPACU
$501K 0.42%
+50,000
New +$500K
HEPS
53
D-Market Electronic Services & Trading
HEPS
$1.01B
$496K 0.41%
200,000
– –
PCAP
54
ProCap Acquisition Corp
PCAP
$327M
$479K 0.4%
47,304
– –
FONR
55
DELISTED
Fonar
FONR
$466K 0.39%
+25,113
New +$378K
DRDB
56
Roman DBDR Acquisition Corp II
DRDB
$325M
$451K 0.37%
43,200
– –
THS
57
DELISTED
Treehouse Foods
THS
$437K 0.36%
+18,530
New +$404K
OACC
58
Oaktree Acquisition Corp III Life Sciences
OACC
$263M
$424K 0.35%
40,032
+2,205
+6% +$23.3K
OKUR
59
OnKure Therapeutics
OKUR
$164M
$421K 0.35%
145,000
-10,490
-7% -$31.4K
GTERU
60
Globa Terra Acquisition Corp Units
GTERU
$158M
$415K 0.34%
40,361
-27
-0.1% -$278
NWAX.U
61
New America Acquisition I Corp Units
NWAX.U
$414K 0.34%
+40,000
New +$415K
BBIO icon
62
CALL
BridgeBio Pharma
BBIO
$16.5B
$382K 0.32%
5,000
– –
TMQ
63
Trilogy Metals
TMQ
$536M
$375K 0.31%
87,000
– –
JANX icon
64
Janux Therapeutics
JANX
$950M
$351K 0.29%
+25,414
New +$598K
WW
65
WW International
WW
$138M
$351K 0.29%
12,000
+1,000
+9% +$27.9K
BCARU
66
D. Boral ARC Acquisition I Corp Units
BCARU
$345K 0.29%
33,780
+6,990
+26% +$71.8K
FERA
67
Fifth Era Acquisition Corp I
FERA
$326M
$344K 0.29%
33,458
+2,468
+8% +$25.5K
PRTH icon
68
Priority Technology Holdings
PRTH
$538M
$332K 0.28%
+61,000
New +$378K
NBIS
69
Nebius Group N.V.
NBIS
$47.7B
$326K 0.27%
3,900
– –
DMIIU
70
Drugs Made In America Acquisition II Corp Unit
DMIIU
$326K 0.27%
+32,551
New +$326K
ABEO icon
71
Abeona Therapeutics
ABEO
$349M
$304K 0.25%
+57,600
New +$290K
FDMT icon
72
4D Molecular Therapeutics
FDMT
$543M
$290K 0.24%
38,665
-4,000
-9% -$40.6K
AVIR icon
73
Atea Pharmaceuticals
AVIR
$386M
$286K 0.24%
80,000
– –
OTGAU
74
OTG Acquisition Corp I Unit
OTGAU
$280K 0.23%
27,520
+2,520
+10% +$25.6K
BHF icon
75
CALL
Brighthouse Financial
BHF
$3.63B
$279K 0.23%
4,300
-10,000
-70% -$588K
1 2
3
4 5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Rangeley Capital held 176 positions worth $120M, up 4.2% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rangeley Capital's Q4 2025 filing shows 49 new, 27 increased, 29 reduced and 53 closed positions. Its largest new stake was Golden Entertainment: 209,881 shares worth $5.71M. The largest sale was WideOpenWest, an estimated $4.89M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Rangeley Capital's largest Q4 2025 buy was Golden Entertainment: 209,881 shares worth $5.71M.
  • Rangeley Capital added most to Repare Therapeutics in Q4 2025, an estimated $1.29M increase.
  • Rangeley Capital's biggest Q4 2025 reduction was Delek US, cutting an estimated $3.71M.
  • Rangeley Capital fully exited WideOpenWest in Q4 2025, selling an estimated $4.89M.
  • Rangeley Capital's ten largest holdings make up 38% of its $120M portfolio in Q4 2025.
  • Rangeley Capital opened 49 new positions and closed 53 in Q4 2025.
  • Rangeley Capital's portfolio value rose 4.2% quarter-over-quarter to $120M.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.